The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Precision diagnosis and treatment of liver cancer in China
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
The Association of HMGB1 Gene with the Prognosis of HCC
Xiao, J., Ding, Y., Huang, J., Li, Q., Liu, Y., Ni, W., Zhang, Y., Zhu, Y., Chen, L., & Chen, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089097 · Cited by 53
RetractedGlobal cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Wilhelm, S. M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1443 · Cited by 4,017
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Huch, M., Dorrell, C., Boj, S. F., van Es, J. H., Li, V. S. W., van de Wetering, M., Sato, T., Hamer, K., Sasaki, N., Finegold, M. J., et al. (2013) · Nature · doi:10.1038/nature11826 · Cited by 1,555
Personalized medicine: Time for one-person trials
Schork, N. J. (2015) · Nature · doi:10.1038/520609a · Cited by 1,223
Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells
Ma, S., Chan, K., Hu, L., Lee, T. K., Wo, J. Y., Ng, I. O., Zheng, B., & Guan, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.025 · Cited by 1,192
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.004 · Cited by 1,149
Self-citationSangro, B., Gomez-Martin, C., de la Mata, M., Iñarrairaegui, M., Garralda, E., Barrera, P., Riezu-Boj, J. I., Larrea, E., Alfaro, C., Sarobe, P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.022 · Cited by 980
Fujii, M., Shimokawa, M., Date, S., Takano, A., Matano, M., Nanki, K., Ohta, Y., Toshimitsu, K., Nakazato, Y., Kawasaki, K., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.003 · Cited by 852
Ye, Q.-H., Qin, L.-X., Forgues, M., He, P., Kim, J. W., Peng, A. C., Simon, R., Li, Y., Robles, A. I., Chen, Y., et al. (2003) · Nature Medicine · doi:10.1038/nm843 · Cited by 850
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
Whittaker, S., Marais, R., & Zhu, A. X. (2010) · Oncogene · doi:10.1038/onc.2010.236 · Cited by 825
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
Duffy, A. G., Ulahannan, S. V., Makorova-Rusher, O., Rahma, O., Wedemeyer, H., Pratt, D., Davis, J. L., Hughes, M. S., Heller, T., ElGindi, M., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.029 · Cited by 819
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Arzumanyan, A., Reis, H. M. G. P. V., & Feitelson, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3449 · Cited by 800
Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H., Befeler, A. S., Roberts, L. R., Reddy, K. R., Harnois, D., Llovet, J. M., Normolle, D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.005 · Cited by 745
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
Zhou, J., Yu, L., Gao, X., Hu, J., Wang, J., Dai, Z., Wang, J.-F., Zhang, Z., Lu, S., Huang, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2697 · Cited by 635
Cancer survival in China, 2003–2005: A population‐based study
Zeng, H., Zheng, R., Guo, Y., Zhang, S., Zou, X., Wang, N., Zhang, L., Tang, J., Chen, J., Wei, K., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29227 · Cited by 622
Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer
Philip, P. A., Mahoney, M. R., Allmer, C., Thomas, J., Pitot, H. C., Kim, G., Donehower, R. C., Fitch, T., Picus, J., & Erlichman, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.696 · Cited by 462
Di Tommaso, L., Franchi, G., Park, Y. N., Fiamengo, B., Destro, A., Morenghi, E., Montorsi, M., Torzilli, G., Tommasini, M., Terracciano, L., et al. (2007) · Hepatology · doi:10.1002/hep.21531 · Cited by 427
Poon, D., Anderson, B. O., Chen, L.-T., Tanaka, K., Lau, W. Y., Van Cutsem, E., Singh, H., Chow, W. C., Ooi, L. L., Chow, P., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70241-4 · Cited by 410
Shen, Q., Fan, J., Yang, X.-R., Tan, Y., Zhao, W., Xu, Y., Wang, N., Niu, Y., Wu, Z., Zhou, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70233-4 · Cited by 394
Self-citationOrganoid cultures for the analysis of cancer phenotypes
Sachs, N., & Clevers, H. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.012 · Cited by 371
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
Marrero, J. A., Romano, P. R., Nikolaeva, O., Steel, L., Mehta, A., Fimmel, C. J., Comunale, M. A., D'Amelio, A., Lok, A. S., & Block, T. M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.028 · Cited by 364
AFP-L3: a new generation of tumor marker for hepatocellular carcinoma
Li, D., Mallory, T., & Satomura, S. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00644-1 · Cited by 358
Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
Gao, H., Li, K., Tu, H., Pan, X., Jiang, H., Shi, B., Kong, J., Wang, H., Yang, S., Gu, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1170 · Cited by 313
Self-citationSawada, Y., Yoshikawa, T., Nobuoka, D., Shirakawa, H., Kuronuma, T., Motomura, Y., Mizuno, S., Ishii, H., Nakachi, K., Konishi, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3044 · Cited by 302
Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden
Nguyen, V. T. T., Law, M. G., & Dore, G. J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01117.x · Cited by 302
Zhu, Z.-W., Friess, H., Wang, L., Abou-Shady, M., Zimmermann, A., Lander, A. D., Korc, M., Kleeff, J., & Büchler, M. W. (2001) · Gut · doi:10.1136/gut.48.4.558 · Cited by 291
Shimizu, S., Takehara, T., Hikita, H., Kodama, T., Tsunematsu, H., Miyagi, T., Hosui, A., Ishida, H., Tatsumi, T., Kanto, T., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26374 · Cited by 266
Zhang, X., Li, J., Shen, F., & Lau, W. Y. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13843 · Cited by 254
EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation
Lanaya, H., Natarajan, A., Komposch, K., Li, L., Amberg, N., Chen, L., Wculek, S. K., Hammer, M., Zenz, R., Peck-Radosavljevic, M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3031 · Cited by 242
Self-citationImmune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions
Hato, T., Goyal, L., Greten, T. F., Duda, D. G., & Zhu, A. X. (2014) · Hepatology · doi:10.1002/hep.27246 · Cited by 241
Yan, W., Chang, Y., Liang, X., Cardinal, J. S., Huang, H., Thorne, S. H., Monga, S. P. S., Geller, D. A., Lotze, M. T., & Tsung, A. (2012) · Hepatology · doi:10.1002/hep.25572 · Cited by 241
(1997) · PubMed · Cited by 239
Glypican‐3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP‐7 signaling
Midorikawa, Y., Ishikawa, S., Iwanari, H., Imamura, T., Sakamoto, H., Miyazono, K., Kodama, T., Makuuchi, M., & Aburatani, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.10856 · Cited by 238
Wang, X. Q., Ongkeko, W. M., Chen, L., Yang, Z. F., Lu, P., Chen, K. K., Lopez, J. P., Poon, R. T. P., & Fan, S. T. (2010) · Hepatology · doi:10.1002/hep.23692 · Cited by 238
Li, L., Chen, L., Hu, L., Liu, Y., Sun, H.-Y., Tang, J., Hou, Y.-J., Chang, Y.-X., Tu, Q.-Q., Feng, G.-S., et al. (2011) · Hepatology · doi:10.1002/hep.24552 · Cited by 234
Self-citationLim, K.-C., Chow, P. K.-H., Allen, J. C., Siddiqui, F. J., Chan, E. S.-Y., & Tan, S.-B. (2012) · British Journal of Surgery · doi:10.1002/bjs.8915 · Cited by 219
Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver Disease
Zinkin, N. T., Grall, F., Bhaskar, K., Otu, H. H., Spentzos, D., Kalmowitz, B., Wells, M., Guerrero, M., Asara, J. M., Libermann, T. A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0586 · Cited by 207
Present and future possibilities for early diagnosis of hepatocellular carcinoma
Stefaniuk, P. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i4.418 · Cited by 184
Feng, M., Gao, W., Wang, R., Chen, W., Man, Y.-G., Figg, W. D., Wang, X. W., Dimitrov, D. S., & Ho, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217868110 · Cited by 183
Developmental roles of the glypicans
De Cat, B., & David, G. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0240 · Cited by 177
Buckley, A. F., Burgart, L. J., Sahai, V., & Kakar, S. (2008) · American Journal of Clinical Pathology · doi:10.1309/wf10qaaed3pp93bh · Cited by 165
Gao, W., Kim, H., Feng, M., Phung, Y., Xavier, C. P., Rubin, J. S., & Ho, M. (2014) · Hepatology · doi:10.1002/hep.26996 · Cited by 164
Nan, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1197 · Cited by 150
Xiang, D., Cheng, Z., Liu, H., Wang, X., Han, T., Sun, W. C., Li, X., Yang, W., Chen, C. Y., Xia, M., et al. (2016) · Hepatology · doi:10.1002/hep.28919 · Cited by 150
Self-citationWang, C., Yang, W. K., Yan, H., Luo, T., Zhang, J., Tang, L. V., Wu, F., Zhang, H., Yu, L., Zheng, L., et al. (2011) · Hepatology · doi:10.1002/hep.24675 · Cited by 149
Self-citationLuo, T., Fu, J., Xu, A., Su, B., Ren, Y., Li, N., Zhu, J., Zhao, X., Dai, R., Cao, J., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1034405 · Cited by 145
Self-citationLi, L., Tang, J., Zhang, B.-H., Yang, W., LiuGao, M., Wang, R.-Y., Tan, Y., Fan, J.-L., Chang, Y.-X., Fu, J., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305715 · Cited by 136
Self-citationGebo, K. A., Chander, G., Jenckes, M. W., Ghanem, K. G., Herlong, H. F., Torbenson, M. S., El‐Kamary, S. S., & Bass, E. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36817 · Cited by 131
Noda, T., Nagano, H., Takemasa, I., Yoshioka, S., Murakami, M., Wada, H., Kobayashi, S., Marubashi, S., Takeda, Y., Dono, K., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605064 · Cited by 122
Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs
Huynh, H. T., Soo, K. C., Chow, P. K. H., Panasci, L. C., & Tran, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2568 · Cited by 111
O'Dwyer, P. J., Giantonio, B. J., Levy, D. E., Kauh, J. S. W., Fitzgerald, D. B., & Benson, A. B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.4143 · Cited by 106
Dargel, C., Bassani‐Sternberg, M., Hasreiter, J., Zani, F., Bockmann, J., Thiele, F., Bohne, F., Wisskirchen, K., Wilde, S., Sprinzl, M. F., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.055 · Cited by 96
Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
Tu, T., Budzinska, M. A., Maczurek, A. E., Cheng, R., Bartolomeo, A. D., Warner, F. J., McCaughan, G. W., McLennan, S. V., & Shackel, N. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069422 · Cited by 94
Gebo, K. A., Chander, G., Jenckes, M. W., Ghanem, K. G., Herlong, H. F., Torbenson, M. S., El‐Kamary, S. S., & Bass, E. B. (2002) · Hepatology · doi:10.1002/hep.1840360711 · Cited by 86
China embraces precision medicine on a massive scale
Cyranoski, D. (2016) · Nature · doi:10.1038/529009a · Cited by 82
Gu, Q., Zhang, B., Sun, H., Xu, Q., Tan, Y., Wang, G., Luo, Q., Xu, W., Yang, S., Li, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3969 · Cited by 80
Self-citationLin, X., Hu, L., Gu, J., Wang, R., Li, L., Tang, J. P., Zhang, B., Yan, X., Zhu, Y., Hu, C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.033 · Cited by 80
Self-citationWang, M.-D., Wu, H., Huang, S., Zhang, H., Qin, C., Zhao, L., Fu, G., Zhou, X., Wang, X., Tang, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6817 · Cited by 76
Self-citationFaivre, S. J., Raymond, É., Douillard, J., Boucher, É., Lim, H. Y., Js, K., Lanzalone, S., Lechuga, M. J., Sherman, L. J., & Cheng, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.3546 · Cited by 71
Hypoxic Suppression of the Cell Cycle GeneCDC25Ain Tumor Cells
Hammer, S., To, K. K. W., Yoo, Y., Koshiji, M., & Huang, E. L. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4515 · Cited by 67
Su, B., Luo, T., Zhu, J., Fu, J., Zhao, X., Chen, L., Zhang, H., Ren, Y., Yu, L., Yang, X., et al. (2014) · Hepatology · doi:10.1002/hep.27551 · Cited by 67
Self-citationSurgical management of hepatocellular carcinoma: Is the jury still out?
Morris‐Stiff, G., Gomez, D., Carino, N. D. L., & Prasad, R. K. (2008) · Surgical Oncology · doi:10.1016/j.suronc.2008.08.003 · Cited by 62
Cai, J., Li, B., Zhu, Y., Fang, X., Zhu, M., Wang, M., Liu, S., Jiang, X., Zheng, J., Zhang, X., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.014 · Cited by 57
Liu, F., Zhang, Y., Peng, Z., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-135 · Cited by 56
Schwartz, J. D., Schwartz, M., Lehrer, D., Cohen, E. I., Sung, M. W., Kinkhabwala, M. M., Siegel, A. B., Holloway, S., Ocean, A. J., & Wadler, S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.4144 · Cited by 55
Interferon–microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis
Yang, Y., Lin, X., Lu, X., Luo, G., Zeng, T., Tang, J. P., Jiang, F., Li, L., Cui, X., Huang, W., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310318 · Cited by 53
Self-citationSerum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma
Li, L., Chen, J., Chen, X., Tang, J. P., Guo, H., Wang, X., Qian, J., Luo, G., He, F., Lu, X., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.028 · Cited by 46
Self-citationPotential role of High mobility group box 1 in hepatocellular carcinoma
Zhou, R.-R., Kuang, X.-Y., Huang, Y., et al. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.969139 · Cited by 30
Cited by
Targeted therapy for hepatocellular carcinoma: Challenges and opportunities
Chen, S., Cao, Q., Wen, W., & Wang, H. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.114428 · Cited by 255
Self-citation
Metadata
- Authors
- Fu, J., & Wang, H.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 412
- Pages
- 283-288
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2765565477
- Cited by
- 301
- References
- 85
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.